Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 14, 2020; 26(42): 6638-6657
Published online Nov 14, 2020. doi: 10.3748/wjg.v26.i42.6638
Published online Nov 14, 2020. doi: 10.3748/wjg.v26.i42.6638
Figure 6 Calibration curve for predicting patient survival.
A: 3-year and B: 5-year overall survival (OS) rates in the primary cohort; C: 3-year OS rate in the validation cohort; D: 1-year and E: 3-year disease-free survival (DFS) rates in the primary cohort; F: 3-year DFS rate in the validation cohort.
- Citation: Wei FZ, Mei SW, Chen JN, Wang ZJ, Shen HY, Li J, Zhao FQ, Liu Z, Liu Q. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy. World J Gastroenterol 2020; 26(42): 6638-6657
- URL: https://www.wjgnet.com/1007-9327/full/v26/i42/6638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i42.6638